Stockscreener 앱 받기
2.49
1.22%
0.03
시간 외 거래:
2.47
-0.02
-0.80%
전일 마감가:
$2.46
열려 있는:
$2.49
하루 거래량:
2.86M
Relative Volume:
0.91
시가총액:
$79.22M
수익:
-
순이익/손실:
$-10.58M
주가수익비율:
-2.075
EPS:
-1.2
순현금흐름:
$-9.21M
1주 성능:
+39.11%
1개월 성능:
+50.00%
6개월 성능:
+158.03%
1년 성능:
+176.67%
1일 변동 폭
$2.37
$2.6398
1주일 범위
$1.83
$2.6398
52주 변동 폭
$0.82
$3.38
Microbot Medical Inc Stock (MBOT) Company Profile
명칭
Microbot Medical Inc
전화
908-938-5561
주소
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
MBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.49 | 79.22M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-01-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-31 | 개시 | Ladenburg Thalmann | Buy |
Microbot Medical Inc 주식(MBOT)의 최신 뉴스
Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Yahoo Finance
Microbot Medical announces proxy statement for annual meeting By Investing.com - Investing.com South Africa
Microbot Medical announces proxy statement for annual meeting - Investing.com
Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com Canada
Microbot’s Liberty Boosts Stock: What’s Next? - timothysykes.com
Microbot Medical modifies shareholder meeting quorum - Investing.com
Microbot Medical's (MBOT) Robotic System Achieves Key Trial Succ - GuruFocus
H.C. Wainwright maintains $9 target on Microbot Medical stock By Investing.com - Investing.com South Africa
Microbot Medical (MBOT) Awaits FDA Decision on LIBERTY® Robot - GuruFocus
Microbot posts pivotal surgical robot data; GE Healthcare hires Patient Care Solutions leader - Yahoo Finance
H.C. Wainwright maintains $9 target on Microbot Medical stock - Investing.com
Microbot Medical reports successful robotic trial By Investing.com - Investing.com Canada
Microbot Medical® Shares Results from Its Pivotal Clinical Trial - GuruFocus
Microbot Medical Data Backs Liberty Endovascular Surgical Robot - Medical Product Outsourcing
Sector Update: Health Care - MarketScreener
Microbot Medical (MBOT) Appoints Paul Mullen as VP of Sales - GuruFocus
Microbot Medical (MBOT) Advances Telesurgery with LIBERTY® Syste - GuruFocus
Microbot Medical (MBOT) Unveils Promising Trial Data for LIBERTY System - GuruFocus
Microbot Medical (MBOT) Secures $13 Million Through Direct Offering - GuruFocus
Microbot Medical shares results from ACCESS-PVI pivotal trial - Vascular News
Microbot Medical Feels a Strong Surge Again? - timothysykes.com
Microbot Medical (MBOT) Surges on Successful Trial Results - GuruFocus
Microbot Medical Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the Liberty® Endovascular Robotic System - MarketScreener
Microbot Medical reports successful robotic trial - Investing.com
Microbot Medical Says Study Shows Endovascular Robotic System Feasible - MarketScreener
Microbot Medical Stock Soars: Is the Rally Sustainable? - timothysykes.com
Microbot Medical Presents Successful Trial Results for LIBERTY System - TipRanks
Microbot Medical stock rises on trial win (MBOT:NASDAQ) - Seeking Alpha
Microbot Medical® Shares Results From Its Pivotal Clinical Trial - MarketScreener
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic ... - Bluefield Daily Telegraph
Microbot Medical® Shares Results from Its Pivotal Clinical - GlobeNewswire
Groundbreaking Clinical Trial: New Robotic System Cuts Surgeon Radiation by 92% - Stock Titan
Microbot Medical (NASDAQ:MBOT) Shares Pass Above Two Hundred Day Moving Average – Here’s Why - Defense World
Microbot Medical to Present ACCESS-PVI Trial Data - TipRanks
REMINDER: Microbot Medical Announces Data from the - GlobeNewswire
Groundbreaking Clinical Trial Results: Revolutionary Endovascular Robot Faces Critical FDA Decision - Stock Titan
Microbot Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Microbot Medical Inc. (MBOT) reports earnings - Quartz
Paul Mullen Chosen to Lead Microbot Medical’s U.S. Sales Force - Medical Product Outsourcing
MICROBOT MEDICAL Earnings Preview: Recent $MBOT Insider Trading, Hedge Fund Activity, and More - Nasdaq
Microbot Medical Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
Microbot Medical (MBOT) to Release Quarterly Earnings on Wednesday - Defense World
Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200 Day Moving Average – What’s Next? - Defense World
Microbot Medical Stock Price, Quotes and Forecasts | NASDAQ:MBOT - Benzinga
Microbot Medical names Paul Mullen as VP, sales - Medical Buyer
Microbot Medical Appoints Seasoned Endovascular Sales - GlobeNewswire
Microbot Medical Appoints New VP Ahead of Product Launch - TipRanks
Microbot Medical appoints Paul Mullen as VP, sales - TipRanks
Microbot Medical Appoints Seasoned Endovascular Sales Executive To Lead Its U.S. Sales Activities For LIBERTY® Endovascular Robotic System - MENAFN.COM
Can This Executive From a $4.94B Acquired Company Drive Microbot's Robotic System to Market Success? - StockTitan
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical Inc (MBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
3.46%
자본화:
|
볼륨(24시간):